Clinical Trials Directory

Trials / Unknown

UnknownNCT03464474

Digital Holographic Microscopy: Evaluation of Histological Disease Activity in Patients With Ulcerative Colitis

Evaluation of Digital Holographic Microscopy for Quantification and Characterization of the Histological Disease Activity in Patients With Ulcerative Colitis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
28 (estimated)
Sponsor
University Hospital Muenster · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Ulcerative colitis (UC) belongs to the group of inflammatory bowel disease (IBD) and is characterized by a chronic relapsing disease course. As uncontrolled intestinal inflammation can lead to severe disease complications, treatment of UC has evolved from sole treatment of symptoms up to histological remission which is marked by the absence of histological inflammation. To correctly assess and quantify the degree of histological inflammation in IBD patients remains difficult. Digital holographic microscopy (DHM) is a new imaging technique belonging to quantitative phase contrast imaging. It is based on the detection of optical path-length delays in a stain-free manner, thereby providing a refractive index which directly correlates to tissue density. This study aims to evaluate the role of DHM for quantifying the degree of histological inflammation in endoscopically acquired biopsies of UC patients in a prospective clinical trial. From 28 UC patients, the investigators will obtain endoscopically acquired colonic biopsies. The investigators will assess the degree of inflammation in these biopsies using DHM and in addition to this an experienced histopathologist will determine the degree of inflammation in these biopsies using a histological scoring system (Nancy-Score = goldstandard). Finally, the investigators will directly correlate the results from DHM analysis to the histological analysis using the Nancy-Score.

Conditions

Interventions

TypeNameDescription
DEVICEdigital holographic microscopyColonic biopsies from all patients will be assessed using digital holographic microscopy in comparison to the existing Goldstandard (histopathological analysis).

Timeline

Start date
2018-04-01
Primary completion
2019-04-01
Completion
2019-10-01
First posted
2018-03-14
Last updated
2018-03-26

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03464474. Inclusion in this directory is not an endorsement.